Comments regarding CMS National Coverage Determination of Next-Generation Sequencing--Germline Correction

In October 2019, CMS revised its earlier National Coverage Decision (NCD) regarding Next-Generation Sequencing (NGS).  CMS recongized that its previous policy had unintended consequences with respect to germline testing and modified its policy.  While ACS CAN supports this policy change, several other aspects of the NCD remain problematic.